Many countries have suspended the use of the AstraZeneca vaccine while the European Union’s medicines regulator investigates whether the shot could be linked to a number of reports of blood clots. Earlier this week, a number of EU nations paused the use of doses that came from a particular batch of AstraZeneca vaccine, after a 49-year-old woman in Austria died of multiple thrombosis on Sunday.
In a statement on Thursday, AstraZeneca said that patient safety was its highest priority. Regulators have clear and stringent efficacy and safety standards for the approval of any new medicine, and that includes COVID-19 Vaccine AstraZeneca. The safety of the vaccine has been extensively studied in Phase III clinical trials and peer-reviewed data confirms the vaccine is generally well tolerated,” the company said in a statement.
Poland’s Health Ministry representative, Wojciech Andrusiewicz said, “I would like to reassure all Poles that there is no reason at this point to stop using the AstraZeneca vaccine. There is absolutely no reason today to make such decision. So far, there has not been a single case of death in Poland that could be linked to AstraZeneca vaccine.”
A World Health Organization expert advisory committee is currently looking at AstraZeneca’s COVID-19 vaccine after some countries paused distribution of it, but there is no reason not to use it. The WHO’s global advisory committee on vaccine safety is currently reviewing the reports and will report on its findings, a spokeswoman said on Friday.